Cargando…
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial
OBJECTIVES: We will investigate the effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen in COVID-19 in patients that have tested positive and are moderately to severely ill. TRIAL DESIGN: This is a single center, open label, randomized, controlled, p...
Autores principales: | Irvani, Seyed Sina Naghibi, Golmohammadi, Maryam, Pourhoseingholi, Mohamad Amin, Shokouhi, Shervin, Darazam, Ilad Alavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268172/ https://www.ncbi.nlm.nih.gov/pubmed/32493468 http://dx.doi.org/10.1186/s13063-020-04382-3 |
Ejemplares similares
-
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2020) -
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2021) -
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2021) -
Resistance of Streptococcus Pneumoniae to Macrolides in Iran
por: Shokouhi, Shervin, et al.
Publicado: (2019) -
Community-acquired methicillin-resistant Staphylococcus aureus carriage rate and antimicrobial susceptibility in a tertiary center, Iran
por: Shokouhi, Shervin, et al.
Publicado: (2017)